Intelligence Profile
Research Papers
Based on the available evidence, research on human growth hormone (HGH/somatropin) appears limited in scope, with most studies focusing on pediatric applications and specific medical conditions.
Key Clinical Studies
The most substantial evidence comes from pediatric endocrinology research. A single-center retrospective cohort study examined recombinant human growth hormone (rhGH) therapy efficacy in children with Turner syndrome, analyzing treatment responses and influencing factors. Similarly, another retrospective study compared long-acting growth hormone therapy responses between children with idiopathic short stature (ISS) versus growth hormone deficiency (GHD), investigating factors that affect treatment outcomes.
A case report documented a novel NPR2 gene variant in familial short stature and described the therapeutic response to rhGH treatment, though sample size limitations apply to case report methodology.
Safety and Monitoring Research
One study investigated potential adverse effects by examining the dose-response relationship between growth hormone treatment and scoliosis development in children with short stature, providing important safety data for clinical practice.
Clinical Trials
Current clinical trial activity is minimal. One Phase 1 trial (NCT07542886) is actively recruiting to study how different injector pen devices affect somatropin (Genotropin) delivery and blood uptake in healthy adults. A completed Phase 4 trial (NCT01380366) examined rhGH effects on intestinal permeability in intestinal failure patients, though detailed results are not provided in this evidence set.
Limitations
The available evidence is notably limited, consisting primarily of retrospective studies and case reports rather than large-scale randomized controlled trials. Most research focuses on pediatric growth disorders, with minimal data on adult applications or broader therapeutic uses of HGH.
This synthesis is based solely on the provided evidence and should not substitute for professional medical consultation regarding HGH therapy decisions.